The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 331:132-133 July 14, 1994 Number 2
NextNext

Urinary Pyridinium Cross-Links: A Noninvasive Diagnostic Test for Ehlers-Danlos Syndrome Type VI

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
To the Editor: Ehlers-Danlos syndrome type VI is an autosomal recessive disorder of connective tissue caused by mutations in the gene for collagen lysyl hydroxylase. This enzyme hydroxylates lysyl residues on newly synthesized intracellular collagen peptides, and its impairment results in a low hydroxylysine content in mature collagen1,2. Diagnosis has required a large skin-biopsy specimen to demonstrate reduced amounts of hydroxylysine in skin collagen and defective lysyl hydroxylase in cultured skin fibroblasts. Here, we report that measurement of the urinary excretion of pyridinium cross-links serves as a simple, noninvasive diagnostic test for this disorder.

After extracellular secretion, specific lysyl . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.